[Contribution to the treatment of ulcus cruris and of progressive scleroderma with adenosine-5-monophosphoric acid (AMP)].
D000227:Adenine Nucleotides / Q000628:therapy*; D000241:Adenosine; D000249:Adenosine Monophosphate; D006801:Humans; D045743:Scleroderma, Diffuse; D012594:Scleroderma, Localized; D012595:Scleroderma, Systemic / Q000628:therapy*; D014647:Varicose Ulcer / Q000628:therapy*
D000227:Adenine Nucleotides; D000249:Adenosine Monophosphate; D000241:Adenosine
ADENOSINE PHOSPHATES/therapy; SCLERODERMA/therapy; VARICOSE ULCER/therapy